By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Les Cardoulines HT1, Allée de la Nertière,

Sophia Antipolis   Valbonne   06560   France
Phone: 33-0-497-218-300 Fax: 33-0-493-641-580


Company News
TxCell Receives EUR 1.7 Million From Bpifrance For Ovasave® Clinical Development In Refractory Crohn’s Disease 1/27/2015 1:31:06 PM
TxCell To Present Its Experience With Cell Therapy At The Cell & Gene Therapy Forum 2015, Washington 1/22/2015 9:51:05 AM
TxCell, Ferring B.V. Strike €75 Million Plus Deal 1/2/2015 6:49:51 AM
TxCell Receives EU Orphan Drug Designation For Col-Treg In The Treatment Of Non-Infectious Uveitis 12/17/2014 11:01:32 AM
TxCell To Present At EU Advanced Therapies Investor Day November 13, In London, UK 11/7/2014 10:56:01 AM
TxCell Reports Revenues For The Third Quarter Of 2014 11/4/2014 12:22:10 PM
TxCell Achieves Positive Results For Col-Treg In A Model Of Autoimmune Uveitis 10/28/2014 6:35:12 AM
TxCell To Present On T Cellular Therapy For Autoimmune Diseases At The 7th National Bio-Therapy Conference 2014, China 10/16/2014 1:00:28 PM
TxCell To Present Latest Developments Of Its Personalized Cell-Based Immunotherapy Platform, Astria, At The 13th TxCell Investor Forum 2014 10/2/2014 9:29:35 AM
TxCell Financial Results For The First Half Of 2014 9/24/2014 11:12:04 AM